New Delhi: The Supreme Court has imposed a fine of Rs.2 lakh on pharma firm RPG Life Sciences for selling a drug without printing the maximum retail price on its pack 25 years ago.
With this order, the apex court has converted the three-month imprisonment awarded by the Madras High Court to the company's production manager and its two distributors into fines.
No MRP on pack
An apex court bench comprising Justices Dalveer Bhandari and Aftab Alam held RPG Life Sciences (earlier Searle India) liable for selling Haloperidol without printing the MRP on its pack.
The case dates back to November 29, 1985, when drug authorities found that 68 bottles containing 100 tablets of Haloperidol each did not have MRP printed on them.
The drug is used in the treatment of acute mania, agitation and similar conditions. The court said RPG had violated rules mentioned in Para 20 of the Drug Prices Control Order (DPCO), 1979, which say a pharma firm has to mention MRP on the bottle or medicine pack. -- PTI